Actuate Therapeutics, Inc. · NASDAQ:ACTU
Voss Capital, LP reported a 7.70% stake in Actuate Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 22, 2026
Voss Capital, LP reported a 7.70% stake in Actuate Therapeutics, Inc., 1,814,263 shares, as a passive investor on Mar 31, 2026. Filed Apr 22, 2026 (Schedule 13G/A).
- Stake
- 7.70%
- Shares
- 1,814,263
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Voss Capital, LP | 7.70% | 1,814,263 |
| Cocke Travis W. | 7.70% | 1,814,263 |
| Voss Advisors GP, LLC | 1.50% | 350,000 |
| Voss Value Master Fund, LP | 1.30% | 300,000 |
| Voss Value-Oriented Special Situations Fund, LP | 0.20% | 50,000 |